Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 17:20:4903-4917.
doi: 10.2147/IJN.S513816. eCollection 2025.

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease

Affiliations
Review

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease

Young Hyun Jung et al. Int J Nanomedicine. .

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are representative neurodegenerative diseases with abnormal energy metabolism and altered distribution and deformation of mitochondria within neurons, particularly in brain regions such as the hippocampus and substantia nigra. Neurons have high energy demands; thus, maintaining a healthy mitochondrial population is important for their biological function. Recently, exosomes have been reported to have mitochondrial regulatory potential and antineurodegenerative properties. This review presents the mitochondrial abnormalities in brain cells associated with AD and PD and the potential of exosomes to treat these diseases. Specifically, it recapitulates research on the molecular mechanisms whereby exosomes regulate mitochondrial biogenesis, fusion/fission dynamics, mitochondrial transport, and mitophagy. Furthermore, this review discusses exosome-triggered signaling pathways that regulate nuclear factor (erythroid-derived 2)-like 2-dependent mitochondrial antioxidation and hypoxia inducible factor 1α-dependent metabolic reprogramming. In summary, this review aims to provide a profound understanding of the regulatory effect of exosomes on mitochondrial function in neurons and to propose exosome-mediated mitochondrial regulation as a promising strategy for AD and PD.

Keywords: Alzheimer’s disease; Parkinson’s disease; exosome; mitochondria; neurodegenerative disease.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

None
Graphical abstract
Figure 1
Figure 1
Illustration showing the effect of molecules delivered by exosomes on mitochondrial biosynthesis in neurons. STIMATE, TFAM mRNA, SIRT1, and various factors delivered via exosomes upregulate PGC1α/NRF1/TFAM signaling. Exosomes also transfer other factors that downregulate miR-30e-5p, which inhibits PGC1α signaling.
Figure 2
Figure 2
Illustration showing the way molecules delivered by exosomes regulate mitochondrial dynamics in neurons. In neurons, the balance between mitochondrial fusion and fission is important for MQC. Nrf2 delivered via exosomes inactivates Drp1, thereby reducing excessive mitochondrial fission. In addition, delivery of factors regulating the expression or transfer of Miro1 via exosomes are expected to transport healthy mitochondria to deteriorated neurons.
Figure 3
Figure 3
Illustration showing that molecules delivered by exosomes regulate mitophagy in neurons. Numerous activators delivered by exosomes, such as BNIP3, miR-138-5p, and miR-let-7e, each send signals that ultimately increase mitophagy. However, epicatechin gallate delivered via exosomes alleviated the excessive apoptosis observed in neurodegenerative diseases.

References

    1. Mukherjee A, Becerra Calixto AD, Chavez M, Delgado JP, Soto C. Mitochondrial transplant to replenish damaged mitochondria: a novel therapeutic strategy for neurodegenerative diseases? Prog mol Biol Transl Sci. 2021;177:49–63. doi:10.1016/bs.pmbts.2020.10.001 - DOI - PubMed
    1. Wang S, Jiang Y, Yang A, Meng F, Zhang J. The expanding burden of neurodegenerative diseases: an unmet medical and social need. Aging Dis. 2024;2024:1. doi:10.14336/AD.2024.1071 - DOI - PubMed
    1. Liu E, Zhang Y, Wang JZ. Updates in Alzheimer’s disease: from basic research to diagnosis and therapies. Transl Neurodegener. 2024;13(1):45. doi:10.1186/s40035-024-00432-x - DOI - PMC - PubMed
    1. Nasb M, Tao W, Chen N. Alzheimer’s disease puzzle: delving into pathogenesis hypotheses. Aging Dis. 2024;15(1):43–73. doi:10.14336/AD.2023.0608 - DOI - PMC - PubMed
    1. Koeglsperger T, Rumpf SL, Schließer P, et al. Neuropathology of incidental Lewy body & prodromal Parkinson’s disease. mol Neurodegener. 2023;18(1):32. doi:10.1186/s13024-023-00622-7 - DOI - PMC - PubMed

LinkOut - more resources